The hair-loss scare mostly comes from one small hormone study. The best direct evidence so far does not show plain creatine monohydrate causing hair loss, though long-term data in women, older adults, and people already prone to androgenetic alopecia are still thin.
Creatine can move creatinine labs, but that is not the same thing as kidney damage. In healthy adults using ordinary creatine monohydrate, the human evidence does not show creatine harming kidney function. Existing kidney disease, abnormal labs, pregnancy, single-kidney context, dehydration risk, or kidney-relevant medications need clinician interpretation.
AOD-9604 fat-loss claims are ahead of the evidence. Animal and mechanism data do not prove reliable human body-composition results, and FDA product-identity/safety concerns plus anti-doping caveats make it high-caution territory rather than a normal supplement shortcut.
Bovine colostrum has some interesting athlete illness and gut-barrier research, but it is not proven as a general recovery, muscle, or immunity upgrade. The claim needs exact outcome, population, dose/form, product-quality, milk-allergy, and cost checks.
BPC-157 is not proven as a safe injury-healing shortcut. The strongest claims lean on animal or mechanism data, while human evidence is small and weak, and the better human proof would need specific injury outcomes, adverse-event reporting, product-quality controls, and follow-up.
CJC-1295 + ipamorelin marketing turns growth-hormone marker effects into promises about fat loss, muscle, sleep, recovery, and anti-aging. The public evidence does not justify that leap; exact-product outcome trials, safety reporting, product-quality controls, and sport-rule checks are still missing.
Dry scooping is not a better pre-workout strategy. It skips label directions, adds powder aspiration and irritation risk, can concentrate stimulant exposure, and has no good performance evidence over mixing the product as directed.
GHK-Cu is not one evidence bucket. Skin-focused, in vitro, animal, and mechanistic studies do not prove injected GHK-Cu reverses aging, heals tissue, or improves recovery, and FDA specifically flags injectable GHK-Cu safety uncertainty.
L-carnitine is real biology, not magic fat loss. The evidence supports a cautious supplement discussion, not the claim that taking more carnitine reliably unlocks stored fat, fixes metabolism, or boosts workouts.
MOTS-c is not proven as a fat-loss, metabolism, performance, or longevity shortcut in people. The public evidence is mostly mechanism, animal, endogenous exercise-response, and association data rather than trials of a defined MOTS-c product, while FDA safety uncertainty and anti-doping caveats make it high-caution territory.
NAD biology is real, but a moved biomarker is not the same as proven anti-aging, energy, muscle, or recovery benefits. NMN, NR, NAD infusions, injections, and longevity stacks each need exact-product human outcome evidence before the hype deserves your money.
A pre-workout feeling powerful is not proof that it is clean, safe, or useful. Caffeine can help some sessions, but finished formulas still need label math, stimulant checks, sleep tradeoffs, product-quality scrutiny, and sport-rule caution.
TB-500 is not proven as a rapid injury-repair shortcut. The stronger evidence is mostly thymosin beta-4 biology, preclinical work, or wound-healing contexts, not replicated human sports-injury trials with pain, function, return-to-training, adverse-event, and product-quality outcomes.
Tesamorelin is not a generic belly-fat or anti-aging shortcut. It has a specific prescription context for excess abdominal fat in adults with HIV-associated lipodystrophy, but FDA labeling says it is not weight-loss management and the evidence should not be stretched into casual wellness use.
The Wolverine stack is not proven as a rapid injury-repair protocol. Combining BPC-157 and TB-500 does not fix the human-evidence gap; it still needs defined-combination trials measuring injury outcomes and adverse events, and safety, product-quality, clinician, and anti-doping caveats still matter.
Generic fat-burner claims are under-proven until the full label, ingredient dose, human outcome data, and safety checks are visible. Some ingredients show small effects in selected trials, but that does not make a product a reliable way to lose fat without diet changes, especially when hidden ingredients, stimulant load, medications, blood pressure, sleep, or athlete product-quality risk are unclear.